1 / 6

Inhalation Anesthesia Market share worth $1.66 bn by 2024

Get more details @ http://bit.ly/2niR4Wg <br>Inhalation Anesthesia Market share dominated by key industry players; includes Baxter International Inc., AbbVie, Piramal Healthcare, Lunan Pharmaceuticals and Hikma

jueekate
Download Presentation

Inhalation Anesthesia Market share worth $1.66 bn by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Asia Pacific Inhalation Anesthesia Market share is set to grow at 4.6% by 2024: Fractovia.org Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights of Inhalation Anesthesia Market: • Global Inhalation Anesthesia Market size contributed $1.24 billion for 2015 with CAGR predicted to be about 3.6% during forecast timeframe. Rapid increase in aging population, growing occurrences of chronic ailments like cancer, heart ailment, respiratory ailment and rising emergency methods are main factors that are projected to drive global industry trends. • Old age population is more prone to suffer from ailments like respiratory ailment, neurological disease, cancer and cardiovascular ailment. Increase in amount of surgical operations along with private and public insurance will boost inhalation anesthesia industry growth. • Global inhalation anesthesia industry is segmented into products like isoflurane, sevoflurane and desflurane. Sevoflurane segment contributed maximum to global inhalation anesthesia market share for 2015. • Growth of the segment can be credited to measurable benefits over other medicines. Also patient recovery after the drug induction is quicker as compared to other anesthetics.

  3. Continued… • Desflurane segment contributed more than $281 million for 2015 and predicted to register CAGR of about 2.31% during forecast period. Exceptional features like reasonable potency and high level of volatility required by vaporizers are predicted to add towards revenue expansion during forecast timeline. • Global inhalation anesthesia market is segmented into geographical locations like MEA, North America, Latin America, APAC and Europe. U.S. inhalation anesthesia industry contributed more than 80.1% to North America inhalation anesthesia market share for 2015. • Growth of the region is primarily credited to high occurrence of chronic ailments, ambulatory services and favorable compensation policies. Additional factors contributing to industry growth are growing occurrence of ailments requiring surgeries and availability of best healthcare amenities along with advanced healthcare setup. • UK inhalation anesthesia industry size was greater than $67 million for 2015 and is predicted to expand at 2.71% during forecast timeline.

  4. U.S. Sevoflurane Market Size, by Application, 2012 - 2024 (USD Million)

  5. Browse Full Market Research Report Inhalation Anesthesia Market @ http://bit.ly/2doUGnO Request for a Sample of this Research report @ https://www.fractovia.org/request-sample/160

  6. Stay In Touch Website: https://www.fractovia.org Social Media:

More Related